IMMUNOGENIC PRODUCT COMPRISING IL-4 AND/OR IL-13 FOR TREATING DISORDERS ASSOCIATED WITH ABERRANT IL-4 AND/OR IL-13 EXPRESSION OR ACTIVITY

摘要

The present invention relates to an immunogenic product comprising a cytokine conjugated with a carrier protein, wherein the cytokine is selected from the group comprising IL-4, IL-13 and mixtures thereof, and wherein the carrier protein is CRM₁₉₇. The present invention further relates to a method for manufacturing the immunogenic product of the invention. The present invention also relates to the therapeutic use of the immunogenic product of the invention for treating an inflammatory disorder associated with aberrant IL-4 and/or IL-13 expression or activity.